Efficacy and pharmacokinetics of glecaprevir and pibrentasvir with concurrent use of acid-reducing agents in patients with chronic HCV infection | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Efficacy and pharmacokinetics of glecaprevir and pibrentasvir with concurrent use of acid-reducing agents in patients with chronic HCV infection

Flamm S, Reddy KR, Zadeikis N, et al. Efficacy and pharmacokinetics of glecaprevir and pibrentasvir with concurrent use of acid-reducing agents in patients with chronic HCV infection. Clin Gastroenterol Hepatol. 2019;17(3):527-535.e6.

Publication Type:

Journal Article

Authors:

Flamm, S; Reddy, K.R.; Zadeikis, N; et, al

Source:

Clin Gastroenterol Hepatol, Volume 17, Issue 3, p.527-535.e6 (2019)

Cited On:

Patients With HIV/HCV Coinfection

Export Citation:

RIS Format

Top